Form 4 Tracker
Katherine Stueland

Director, CHIEF EXECUTIVE OFFICER · 7 filings · Latest: Apr 29, 2026

GeneDx Holdings Corp.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
WGS
Katherine StuelandMar 17, 2025
Proposed Sale
$96.7010,559$1.0M
WGS
Katherine StuelandMar 13, 2025
Proposed Sale
$89.421,078$96.4K
WGS
Katherine StuelandMar 10, 2025
Proposed Sale
$94.732,731$258.7K
WGS
Katherine StuelandJan 29, 2025
Proposed Sale
$78.461,657$130.0K
WGS
Stueland KatherineJan 7, 2025
Proposed Sale
$93.9351,420$4.8M
WGS
Stueland KatherineJan 2, 2025
Proposed Sale
$77.7518,006$1.4M
WGS
Katherine StuelandDec 16, 2024
Proposed Sale
$76.7510,501$806.0K
WGS
Katherine StuelandDec 9, 2024
Proposed Sale
$76.373,661$279.6K
WGS
Stueland KatherineNov 15, 2024
Proposed Sale
$70.0245,415$3.2M
WGS
Katherine StuelandOct 29, 2024
Proposed Sale
$66.602,154$143.5K
WGS
Katherine StuelandSep 16, 2024
Proposed Sale
$37.5910,501$394.7K
WGS
Katherine StuelandSep 9, 2024
Proposed Sale
$33.333,639$121.3K

← Previous

Page 2 of 2